Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 4 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 11400143

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  2. US 11376311

    Methods of treating microbial infection and inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  3. US 11376247

    Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  4. US 11364293

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted

  5. US 11324811

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 10, 2022 · Expires May 5, 2042

    granted

  6. US 11304996

    Yeast-based immunotherapy and type I interferon sensitivity

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  7. US 11298309

    Topical silk compositions and methods of using

    The Regents of the University of Colorado · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  8. US 11298441

    Biodegradable biomimetics of growth plate cartilage for the treatment of physeal injuries

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  9. US 11273127

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 15, 2022 · Expires Mar 10, 2042

    granted

  10. US 11267859

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  11. US 11253506

    Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  12. US 11230565

    Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry

    The Regents of the University of Colorado · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  13. US 11219552

    Intraocular filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  14. US 11207211

    Lacrimal drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  15. US 11185580

    Compositions, methods and uses for improved human papilloma virus constructs

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  16. US 11181536

    Methods for monitoring treatment of chronic liver disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  17. US 11169142

    Viscoelastic analysis in patients with disease associated with cardiovascular system

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  18. US 11160908

    Intraocular drug delivery and filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  19. US 11155821

    Compositions and methods for tagging ribonucleic acids

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  20. US 11147946

    Venous access catheters and methods for portal venous system catheterization

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

  21. US 11137409

    Identification of novel disease states using viscoelastic analysis in the presence of a thrombolytic agent

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  22. US 11130795

    CD154 peptides and methods of inhibiting CD40 interactions with CD154

    The Regents of the University of Colorado · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  23. US 11110080

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted

  24. US 11083720

    Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.